Capital Research Global Investors Dexcom Inc Transaction History
Capital Research Global Investors
- $428 Billion
- Q1 2024
A detailed history of Capital Research Global Investors transactions in Dexcom Inc stock. As of the latest transaction made, Capital Research Global Investors holds 13,435,892 shares of DXCM stock, worth $1.6 Billion. This represents 0.43% of its overall portfolio holdings.
Number of Shares
13,435,892
Previous 15,296,032
12.16%
Holding current value
$1.6 Billion
Previous $1.9 Billion
1.82%
% of portfolio
0.43%
Previous 0.48%
Shares
15 transactions
Others Institutions Holding DXCM
# of Institutions
1,123Shares Held
352MCall Options Held
4.19MPut Options Held
4.54M-
Vanguard Group Inc Valley Forge, PA44.6MShares$5.3 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY33.9MShares$4.03 Billion0.11% of portfolio
-
State Street Corp Boston, MA16.2MShares$1.93 Billion0.1% of portfolio
-
Baillie Gifford & CO15.7MShares$1.86 Billion1.72% of portfolio
-
Sands Capital Management, LLC Arlington, VA10.9MShares$1.29 Billion4.43% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $45.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...